KIMBERLY ROBERTSON: Open Payments
NPI 1407333446 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,560 in 172 payments from 33 companies in 2025. Trend: 2023 $1,925 · 2024 $1,855 · 2025 $3,560
Food & beverage: $3,560
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $759 |
| PFIZER INC. | 35 | $455 |
| UCB, Inc. | 14 | $381 |
| Alexion Pharmaceuticals, Inc. | 8 | $174 |
| Biogen, Inc. | 10 | $144 |
| Lundbeck LLC | 7 | $140 |
| ACADIA Pharmaceuticals Inc | 6 | $139 |
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| SK Life Science, Inc. | 5 | $125 |
| Novartis Pharmaceuticals Corporation | 6 | $115 |
Products named: QULIPTA, NURTEC ODT, BOTOX, PANZYGA, ULTOMIRIS, UBRELVY, NUPLAZID, Briviact.
Industry payments across IN — which companies pay providers there.
